REPROS THERAPEUTICS INC's ticker is RPRX and the CUSIP is 76028H209. A total of 45 filers reported holding REPROS THERAPEUTICS INC in Q2 2016. The put-call ratio across all filers is 0.15 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $0 | – | 400 | +166.7% | 0.00% | – |
| Q3 2017 | $0 | – | 150 | 0.0% | 0.00% | – |
| Q2 2017 | $0 | – | 150 | 0.0% | 0.00% | – |
| Q1 2017 | $0 | – | 150 | 0.0% | 0.00% | – |
| Q4 2016 | $0 | – | 150 | 0.0% | 0.00% | – |
| Q3 2016 | $0 | – | 150 | 0.0% | 0.00% | – |
| Q2 2016 | $0 | -100.0% | 150 | -84.6% | 0.00% | – |
| Q1 2016 | $1,000 | 0.0% | 975 | 0.0% | 0.00% | – |
| Q4 2015 | $1,000 | -93.8% | 975 | -54.4% | 0.00% | – |
| Q3 2015 | $16,000 | +100.0% | 2,140 | +86.1% | 0.00% | – |
| Q2 2015 | $8,000 | -20.0% | 1,150 | 0.0% | 0.00% | – |
| Q1 2015 | $10,000 | -9.1% | 1,150 | 0.0% | 0.00% | – |
| Q4 2014 | $11,000 | -35.3% | 1,150 | -33.9% | 0.00% | – |
| Q3 2014 | $17,000 | +142.9% | 1,740 | +335.0% | 0.00% | – |
| Q2 2013 | $7,000 | – | 400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 1,001,000 | $970,000 | 0.21% |
| Allegis Investment Advisors, LLC | 341,669 | $331,000 | 0.19% |
| GENERAL AMERICAN INVESTORS CO INC | 396,123 | $384,000 | 0.04% |
| Alambic Investment Management, L.P. | 114,591 | $111,000 | 0.04% |
| Gruss Capital Management LP | 600,000 | $582,000 | 0.02% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 102,086 | $99,000 | 0.01% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 323,429 | $314,000 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 27,931 | $27,000 | 0.00% |
| BENJAMIN F. EDWARDS & COMPANY, INC. | 2,700 | $3,000 | 0.00% |
| Airain ltd | 13,690 | $13,000 | 0.00% |